Paper17575260
Demonstrating the C-terminal boundary of the HIV 1 fusion conformation in a dynamic ongoing fusion process and implication for fusion inhibition.
Wexler-Cohen Y and 1 other. FASEB J, 2007. Cited by 74 papers, by iCite.
Cite this record
ConductScience Library. Demonstrating the C-terminal boundary of the HIV 1 fusion conformation in a dynamic ongoing fusion process and implication for fusion inhibition. Papers, record 17575260. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17575260
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Demonstrating the C-terminal boundary of the HIV 1 fusion conformation in a dynamic ongoing fusion process and implication for fusion inhibition.
- PubMed
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV-1 | Major topic |
| Membrane Fusion | Major topic |
| Protein Conformation |
Source PubMed
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38910421 | Design of Artificial C-Peptides as Potential Anti-HIV-1 Inhibitors Based on 6-HB Formation Mechanism. | Protein Pept Lett | 2024 | https://conductscience.org/library/papers/38910421 | PubMed |
| 31619552 | The Tryptophan-Rich Motif of HIV-1 gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of gp41 and Its Inhibitors. | J Virol | 2019 | https://conductscience.org/library/papers/31619552 | PubMed |
| 30901967 | A Peptide-Based HIV-1 Fusion Inhibitor with Two Tail-Anchors and Palmitic Acid Exhibits Substantially Improved In Vitro and Ex Vivo Anti-HIV-1 Activity and Prolonged In Vivo Half-Life. | Molecules | 2019 | https://conductscience.org/library/papers/30901967 | PubMed |
| 30867304 | Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-Lasting Antiviral Activity. | J Virol | 2019 | https://conductscience.org/library/papers/30867304 | PubMed |
| 30716118 | Monotherapy with a low-dose lipopeptide HIV fusion inhibitor maintains long-term viral suppression in rhesus macaques. | PLoS Pathog | 2019 | https://conductscience.org/library/papers/30716118 | PubMed |
| 30192544 | De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery. | J Med Chem | 2018 | https://conductscience.org/library/papers/30192544 | PubMed |
| 30090269 | De novo design of isopeptide bond-tethered triple-stranded coiled coils with exceptional resistance to unfolding and proteolysis: implication for developing antiviral therapeutics. | Chem Sci | 2015 | https://conductscience.org/library/papers/30090269 | PubMed |
| 29899103 | Design of Novel HIV-1/2 Fusion Inhibitors with High Therapeutic Efficacy in Rhesus Monkey Models. | J Virol | 2018 | https://conductscience.org/library/papers/29899103 | PubMed |
| 29535974 | Structural Insights into the Mechanisms of Action of Short-Peptide HIV-1 Fusion Inhibitors Targeting the Gp41 Pocket. | Front Cell Infect Microbiol | 2018 | https://conductscience.org/library/papers/29535974 | PubMed |
| 28659478 | Enfuvirtide (T20)-Based Lipopeptide Is a Potent HIV-1 Cell Fusion Inhibitor: Implications for Viral Entry and Inhibition. | J Virol | 2017 | https://conductscience.org/library/papers/28659478 | PubMed |
| 27908751 | Enhanced potency of bivalent small molecule gp41 inhibitors. | Bioorg Med Chem | 2017 | https://conductscience.org/library/papers/27908751 | PubMed |
| 27562370 | Site-specific Isopeptide Bridge Tethering of Chimeric gp41 N-terminal Heptad Repeat Helical Trimers for the Treatment of HIV-1 Infection. | Sci Rep | 2016 | https://conductscience.org/library/papers/27562370 | PubMed |
| 26506247 | The C34 Peptide Fusion Inhibitor Binds to the Six-Helix Bundle Core Domain of HIV-1 gp41 by Displacement of the C-Terminal Helical Repeat Region. | Biochemistry | 2015 | https://conductscience.org/library/papers/26506247 | PubMed |
| 26187042 | Sutherlandia frutescens may exacerbate HIV-associated neuroinflammation. | J Negat Results Biomed | 2015 | https://conductscience.org/library/papers/26187042 | PubMed |
| 25646644 | Swapped-domain constructs of the glycoprotein-41 ectodomain are potent inhibitors of HIV infection. | ACS Chem Biol | 2015 | https://conductscience.org/library/papers/25646644 | PubMed |
| 25451066 | Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein. | Virus Res | 2014 | https://conductscience.org/library/papers/25451066 | PubMed |
| 24094817 | Modular assembly of dimeric HIV fusion inhibitor peptides with enhanced antiviral potency. | Bioorg Med Chem Lett | 2013 | https://conductscience.org/library/papers/24094817 | PubMed |
| 23893342 | NMR-assisted computational studies of peptidomimetic inhibitors bound in the hydrophobic pocket of HIV-1 glycoprotein 41. | J Comput Aided Mol Des | 2013 | https://conductscience.org/library/papers/23893342 | PubMed |
| 23565220 | Conjugation of cholesterol to HIV-1 fusion inhibitor C34 increases peptide-membrane interactions potentiating its action. | PLoS One | 2013 | https://conductscience.org/library/papers/23565220 | PubMed |
| 22872679 | Sphingopeptides: dihydrosphingosine-based fusion inhibitors against wild-type and enfuvirtide-resistant HIV-1. | FASEB J | 2012 | https://conductscience.org/library/papers/22872679 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17575260
GET https://conductscience.org/api/papers/v1/17575260/cited_by?page=2